H & H Ph. - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

creon 25,000

viatris limited - pancreatin 300mg (amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u.); pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u; pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u - modified release capsule - 300 mg - active: pancreatin 300mg (amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u.) excipient: acetone dibutyl phthalate dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow liquid paraffin macrogol 4000 propyl alcohol titanium dioxide active: pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate active: pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

New Zealand - English - Medsafe (Medicines Safety Authority)

creon 10,000

viatris limited - pancreatin 150mg (amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u.); pancreatin 150mg equivalent to amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u. - modified release capsule - 150 mg - active: pancreatin 150mg (amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u.) excipient: acetone dibutyl phthalate dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow liquid paraffin macrogol 4000 propyl alcohol titanium dioxide active: pancreatin 150mg equivalent to amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u. excipient: cetyl alcohol dimeticone ferrosoferric oxide gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Kenya - English - Pharmacy and Poisons Board

s- pyrimac (sulfadoxine and pyrimethamine dispersible tablet

sulfadoxine ph. int. and pyrimethamine ph. int. - dispersible tablet - sulfadoxine ph. int.----500mg pyrimethamine ph.… - pyrimethamine combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

creon 35,000 pancreatic extract 420 mg capsule bottle

viatris pty ltd - pancreatic extract, quantity: 420 mg (equivalent: lipase, qty 35000 ph eur unit; equivalent: amylase, qty 25200 ph eur unit; equivalent: protease, qty 1400 ph eur unit) - capsule - excipient ingredients: macrogol 4000; hypromellose phthalate; cetyl alcohol; triethyl citrate; dimeticone 1000; gelatin; iron oxide red; iron oxide yellow; iron oxide black; titanium dioxide; sodium lauryl sulfate - creon is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: ? cystic fibrosis ? chronic pancreatitis ? pancreatic surgery ? gastrointestinal bypass surgery (e.g. bilroth ii gastroenterostomy) ? ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm)

Ireland - English - HPRA (Health Products Regulatory Authority)

maintelyte solution for infusion

baxter holding b.v. - sodium chloride; glucose monohydrate ph. eur.; sodium acetate, trihydrate; potassium chloride ph. eur.; magnesium chloride hexahydrate ph. eur. - solution for infusion - 55.00 gram(s)/litre - electrolytes with carbohydrates

United States - English - NLM (National Library of Medicine)

ph.hubby 1g sun cream intensive protection- titanium dioxide, ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triaz

ph hubby co., ltd. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), bemotrizinol (unii: pwz1720cbh) (bemotrizinol - unii:pwz1720cbh) - prevention of hyperpigmentation&aging induced by uva/uvb rays all year-round. apply every morning at the end of the skincare routine of going out.

United States - English - NLM (National Library of Medicine)

ph.hubby pink bb tone up sun- titanium dioxide, ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triazine, niacinami

United States - English - NLM (National Library of Medicine)

ph.hubby beige bb tone up sun- titanium dioxide, ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triazine, niacinam

Ireland - English - HPRA (Health Products Regulatory Authority)

maalox plus chewable tablets 200mg/200mg/25mg

sanofi-aventis ireland limited t/a sanofi - aluminium oxide, hydrated ph. eur; magnesium hydroxide ph. eur.; dimeticone ph. eur. (as simeticone ph. eur.) - chewable tablet - 200mg/200mg/25 milligram(s) - antacids with antiflatulents; ordinary salt combinations and antiflatulents

Ireland - English - HPRA (Health Products Regulatory Authority)

maalox plus chewable tablets 200mg/200mg/25mg

opella healthcare france sas t/a sanofi - aluminium oxide, hydrated ph. eur; magnesium hydroxide ph. eur.; dimeticone ph. eur. (as simeticone ph. eur.) - chewable tablet - 200mg/200mg/25 milligram(s) - antacids with antiflatulents; ordinary salt combinations and antiflatulents